Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by elgin1on Oct 16, 2019 5:18pm

59 Views

Post# 30237855

RE:RE:RE:RE:RE:News

Redbaron2211 wrote: It says "measured up to 30 days and ongoing".

Medtronics continuous glucose monitoring system is just that a continuous monitoring sytem.

In the last NR it was "presence of stimulated blood levels of C-peptide and insulin at the observed 90-day post-transplant"

Difference now is C-peptide is found not only when stimulated but also while fasting.

Yes my take is that c peptide is being produced constantly since implantattion and we are now past the 6 month period with excellent results.